chrX-66604490-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_021783.5(EDA2R):c.283C>T(p.Arg95Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000282 in 1,206,124 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 10 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000036 ( 0 hom., 1 hem., cov: 22)
Exomes 𝑓: 0.000027 ( 0 hom. 9 hem. )
Consequence
EDA2R
NM_021783.5 missense
NM_021783.5 missense
Scores
3
3
11
Clinical Significance
Conservation
PhyloP100: 1.67
Genes affected
EDA2R (HGNC:17756): (ectodysplasin A2 receptor) The protein encoded by this gene is a type III transmembrane protein of the TNFR (tumor necrosis factor receptor) superfamily, and contains cysteine-rich repeats and a single transmembrane domain. This protein binds to the EDA-A2 isoform of ectodysplasin, which plays an important role in maintenance of hair and teeth. Alternatively spliced transcript variants encodes distinct protein isoforms. [provided by RefSeq, Apr 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.073266745).
BS2
High Hemizygotes in GnomAdExome4 at 9 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EDA2R | NM_021783.5 | c.283C>T | p.Arg95Cys | missense_variant | 4/7 | ENST00000374719.8 | NP_068555.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EDA2R | ENST00000374719.8 | c.283C>T | p.Arg95Cys | missense_variant | 4/7 | 1 | NM_021783.5 | ENSP00000363851 | P1 | |
EDA2R | ENST00000253392.5 | c.283C>T | p.Arg95Cys | missense_variant | 3/6 | 1 | ENSP00000253392 | |||
EDA2R | ENST00000396050.5 | c.283C>T | p.Arg95Cys | missense_variant | 3/7 | 5 | ENSP00000379365 | |||
EDA2R | ENST00000451436.6 | c.283C>T | p.Arg95Cys | missense_variant | 4/7 | 5 | ENSP00000415242 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000358 AC: 4AN: 111648Hom.: 0 Cov.: 22 AF XY: 0.0000296 AC XY: 1AN XY: 33798
GnomAD3 genomes
AF:
AC:
4
AN:
111648
Hom.:
Cov.:
22
AF XY:
AC XY:
1
AN XY:
33798
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000443 AC: 8AN: 180743Hom.: 0 AF XY: 0.0000459 AC XY: 3AN XY: 65401
GnomAD3 exomes
AF:
AC:
8
AN:
180743
Hom.:
AF XY:
AC XY:
3
AN XY:
65401
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000274 AC: 30AN: 1094476Hom.: 0 Cov.: 29 AF XY: 0.0000250 AC XY: 9AN XY: 360262
GnomAD4 exome
AF:
AC:
30
AN:
1094476
Hom.:
Cov.:
29
AF XY:
AC XY:
9
AN XY:
360262
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000358 AC: 4AN: 111648Hom.: 0 Cov.: 22 AF XY: 0.0000296 AC XY: 1AN XY: 33798
GnomAD4 genome
AF:
AC:
4
AN:
111648
Hom.:
Cov.:
22
AF XY:
AC XY:
1
AN XY:
33798
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
9
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 04, 2022 | The c.283C>T (p.R95C) alteration is located in exon 3 (coding exon 3) of the EDA2R gene. This alteration results from a C to T substitution at nucleotide position 283, causing the arginine (R) at amino acid position 95 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
T;.;T;.
FATHMM_MKL
Benign
D
LIST_S2
Benign
.;T;T;.
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N;N;N
MutationTaster
Benign
D;D;D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;.;D
REVEL
Benign
Sift
Pathogenic
D;D;.;D
Sift4G
Benign
T;T;T;T
Polyphen
B;B;B;B
Vest4
MVP
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at